Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 1
1961 1
1975 2
1976 1
1979 1
1985 1
2012 2
2013 3
2014 3
2015 13
2016 7
2017 12
2018 5
2019 6
2020 16
2021 25
2022 17
2023 10
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

118 results

Results by year

Filters applied: . Clear all
Page 1
A Randomized Clinical Trial of Anti-IL-6 Antibody Clazakizumab in Late Antibody-Mediated Kidney Transplant Rejection.
Doberer K, Duerr M, Halloran PF, Eskandary F, Budde K, Regele H, Reeve J, Borski A, Kozakowski N, Reindl-Schwaighofer R, Waiser J, Lachmann N, Schranz S, Firbas C, Mühlbacher J, Gelbenegger G, Perkmann T, Wahrmann M, Kainz A, Ristl R, Halleck F, Bond G, Chong E, Jilma B, Böhmig GA. Doberer K, et al. Among authors: halleck f. J Am Soc Nephrol. 2021 Mar;32(3):708-722. doi: 10.1681/ASN.2020071106. Epub 2020 Dec 18. J Am Soc Nephrol. 2021. PMID: 33443079 Free PMC article. Clinical Trial.
eHealth in transplantation.
Duettmann W, Naik MG, Zukunft B, Osmonodja B, Bachmann F, Choi M, Roller R, Mayrdorfer M, Halleck F, Schmidt D, Budde K. Duettmann W, et al. Among authors: halleck f. Transpl Int. 2021 Jan;34(1):16-26. doi: 10.1111/tri.13778. Epub 2020 Nov 27. Transpl Int. 2021. PMID: 33111393 Free article. Review.
Risks and benefits of everolimus.
Budde K, Halleck F. Budde K, et al. Among authors: halleck f. Transpl Int. 2019 Nov;32(11):1124-1126. doi: 10.1111/tri.13489. Transpl Int. 2019. PMID: 31397931 Free article. No abstract available.
[Immunosuppression and its use in kidney transplantation].
Paliege A, Bamoulid J, Bachmann F, Staeck O, Halleck F, Khadzhynov D, Brakemeier S, Dürr M, Budde K. Paliege A, et al. Among authors: halleck f. Urologe A. 2015 Oct;54(10):1376-84. doi: 10.1007/s00120-015-3909-x. Urologe A. 2015. PMID: 26459580 Review. German.
An evaluation of sirolimus in renal transplantation.
Halleck F, Duerr M, Waiser J, Huber L, Matz M, Brakemeier S, Liefeldt L, Neumayer HH, Budde K. Halleck F, et al. Expert Opin Drug Metab Toxicol. 2012 Oct;8(10):1337-56. doi: 10.1517/17425255.2012.719874. Epub 2012 Aug 28. Expert Opin Drug Metab Toxicol. 2012. PMID: 22928953 Review.
Advances in pharmacotherapy to treat kidney transplant rejection.
Bamoulid J, Staeck O, Halleck F, Dürr M, Paliege A, Lachmann N, Brakemeier S, Liefeldt L, Budde K. Bamoulid J, et al. Among authors: halleck f. Expert Opin Pharmacother. 2015;16(11):1627-48. doi: 10.1517/14656566.2015.1056734. Expert Opin Pharmacother. 2015. PMID: 26159444 Review.
New perspectives of immunosuppression.
Halleck F, Friedersdorff F, Fuller TF, Matz M, Huber L, Dürr M, Schütz M, Budde K. Halleck F, et al. Transplant Proc. 2013 Apr;45(3):1224-31. doi: 10.1016/j.transproceed.2013.02.033. Transplant Proc. 2013. PMID: 23622665 Review.
Transplanting HCV-Infected Kidneys into Uninfected Recipients.
Halleck F, Budde K, Duerr M, Staeck O, Hofmann J, Eisenberger U, Herzer K, Sterneck M, Gottlieb J, Schulz U. Halleck F, et al. N Engl J Med. 2017 Sep 14;377(11):1103-4. doi: 10.1056/NEJMc1709315. N Engl J Med. 2017. PMID: 28902583 No abstract available.
118 results